Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

L Bouillet, M Dougados, O Fain, D Farge… - Annals of the …, 2005 - ard.bmj.com
Objective: To assess the tolerance and efficacy of rituximab in patients with various
autoimmune diseases seen in daily rheumatological practice. Methods: 866 rheumatology …

[PDF][PDF] Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

JE Gottenberg, L Guillevin, O Lambotte, B Combe… - Ann Rheum …, 2005 - researchgate.net
Objective: To assess the tolerance and efficacy of rituximab in patients with various
autoimmune diseases seen in daily rheumatological practice. Methods: 866 rheumatology …

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

JE Gottenberg, L Guillevin, O Lambotte… - Annals of the …, 2005 - search.proquest.com
Objective: To assess the tolerance and efficacy of rituximab in patients with various
autoimmune diseases seen in daily rheumatological practice. Methods: 866 rheumatology …

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

JE Gottenberg, L Guillevin… - Annals of the …, 2005 - pubmed.ncbi.nlm.nih.gov
Objective To assess the tolerance and efficacy of rituximab in patients with various
autoimmune diseases seen in daily rheumatological practice. Methods 866 rheumatology …

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

J Gottenberg, L Guillevin, O Lambotte… - Annals of the …, 2005 - ncbi.nlm.nih.gov
Objective: To assess the tolerance and efficacy of rituximab in patients with various
autoimmune diseases seen in daily rheumatological practice. Methods: 866 rheumatology …

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.

JE Gottenberg, L Guillevin, O Lambotte… - Annals of the …, 2004 - europepmc.org
Objective To assess the tolerance and efficacy of rituximab in patients with various
autoimmune diseases seen in daily rheumatological practice. Methods 866 rheumatology …

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

JE Gottenberg, L Guillevin, O Lambotte… - Annals of the …, 2005 - pure.urosario.edu.co
Objective: To assess the tolerance and efficacy of rituximab in patients with various
autoimmune diseases seen in daily rheumatological practice. Methods: 866 rheumatology …

[引用][C] Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

JE Gottenberg - Annals of the Rheumatic Diseases, 2005 - cir.nii.ac.jp
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune
diseases | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

[引用][C] Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

JE GOTTENBERG, L GUILLEVIN… - Annals of the …, 2005 - pascal-francis.inist.fr
Author GOTTENBERG, J.-E 1; GUILLEVIN, L 2; FAIN, O 11; FARGE, D 12; KYNDT, X 13;
LORTHOLARY, O 14; MASSON, C 15; MOURA, B 16; REMY, P 17; THOMAS, T 18; …

Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases

JE Gottenberg, L Guillevin, O Lambotte… - Annals of the …, 2004 - ard.bmj.com
Objective. To assess the tolerance and efficacy of rituximab in patients with various
autoimmune diseases seen in daily rheumatological practice. Patients and Methods. Eight …